Free Trial
NASDAQ:NAOV

NanoVibronix (NAOV) Stock Price, News & Analysis

NanoVibronix logo
$0.51
0.00 (0.00%)
(As of 10/31/2024 ET)

About NanoVibronix Stock (NASDAQ:NAOV)

Key Stats

Today's Range
$0.49
$0.53
50-Day Range
$0.50
$0.73
52-Week Range
$0.46
$1.55
Volume
126,008 shs
Average Volume
95,393 shs
Market Capitalization
$1.41 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its product portfolio includes UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing by using ultrasound to increase local capillary perfusion and tissue oxygenation. It sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, Australia, India, and internationally. The company was incorporated in 2003 and is headquartered in Elmsford, New York.

NanoVibronix Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
5th Percentile Overall Score

NAOV MarketRank™: 

NanoVibronix scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of NanoVibronix is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of NanoVibronix is -0.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    NanoVibronix has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about NanoVibronix's valuation and earnings.
  • Percentage of Shares Shorted

    18.67% of the float of NanoVibronix has been sold short.
  • Short Interest Ratio / Days to Cover

    NanoVibronix has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in NanoVibronix has recently increased by 3,311.92%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    NanoVibronix does not currently pay a dividend.

  • Dividend Growth

    NanoVibronix does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    18.67% of the float of NanoVibronix has been sold short.
  • Short Interest Ratio / Days to Cover

    NanoVibronix has a short interest ratio ("days to cover") of 4.2.
  • Change versus previous month

    Short interest in NanoVibronix has recently increased by 3,311.92%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    NanoVibronix has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for NanoVibronix this week, compared to 0 articles on an average week.
  • Search Interest

    4 people have searched for NAOV on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added NanoVibronix to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, NanoVibronix insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 3.60% of the stock of NanoVibronix is held by insiders.

  • Percentage Held by Institutions

    Only 16.39% of the stock of NanoVibronix is held by institutions.

  • Read more about NanoVibronix's insider trading history.
Receive NAOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoVibronix and its competitors with MarketBeat's FREE daily newsletter.

NAOV Stock News Headlines

Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time Nvidia makes a chip?
NanoVibronix Issues Letter to Stockholders
See More Headlines

NAOV Stock Analysis - Frequently Asked Questions

NanoVibronix's stock was trading at $1.15 at the beginning of the year. Since then, NAOV stock has decreased by 55.8% and is now trading at $0.5080.
View the best growth stocks for 2024 here
.

NanoVibronix, Inc. (NASDAQ:NAOV) announced its earnings results on Wednesday, August, 14th. The company reported ($0.25) earnings per share for the quarter. The firm earned $0.82 million during the quarter. NanoVibronix had a negative trailing twelve-month return on equity of 74.98% and a negative net margin of 83.49%.

NanoVibronix shares split on the morning of Thursday, October 13th 2022. The 2-1 split was announced on Thursday, October 13th 2022. The newly created shares were payable to shareholders after the market closes on Thursday, October 13th 2022. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Shares of NAOV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that NanoVibronix investors own include Exela Technologies (XELA), Assertio (ASRT), Meta Platforms (META), T2 Biosystems (TTOO), NIO (NIO), Senseonics (SENS) and SNDL (SNDL).

Company Calendar

Last Earnings
8/14/2024
Today
10/31/2024
Next Earnings (Estimated)
11/11/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical appliances & supplies
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NAOV
Employees
20
Year Founded
N/A

Profitability

Net Income
$-3,710,000.00
Pretax Margin
-82.75%

Debt

Sales & Book Value

Annual Sales
$2.28 million
Book Value
$1.95 per share

Miscellaneous

Free Float
2,684,000
Market Cap
$1.41 million
Optionable
Not Optionable
Beta
1.50
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

This page (NASDAQ:NAOV) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners